SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

Viemed Healthcare, Inc. (VMD) News

Track canonical SquawkNews coverage tagged to VMD, Viemed Healthcare, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 6 indexed stories across 4 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol VMD Asset equity Sector Markets 90 days 6 Last 8.82 Updated Sep 24, 2026, 10:32 PM UTC Open live news feed
L Viemed Healthcare, Inc. (VMD) President Sets 10b5-1 Plan to Sell Up to 246K Shares Viemed Healthcare, Inc. said President Michael Moore adopted a Rule 10b5-1 ASDP to sell up to 246,000 shares over ~1 year ending Nov. 30, 2027, with sales starting as early as Dec. 24, 2026 and subject to a minimum floor EQUITY | Sep 24, 2026, 10:32 PM UTC L Viemed Healthcare Announces Adoption of Automatic Securities Disposition Plan by President Michael Moore LAFAYETTE, LA / / September 24, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") NASDAQ:VMD, a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, today anno NEWS | Sep 24, 2026, 10:31 PM UTC L VMD: Strong organic growth, service diversification, and stable financials drive continued expansion VMD: Strong organic growth, service diversification, and stable financials drive continued expansion EQUITY | Aug 26, 2026, 11:04 PM UTC L VMD: Strong organic growth, diversification, and stable financials drive expansion in home healthcare VMD: Strong organic growth, diversification, and stable financials drive expansion in home healthcare EQUITY | Aug 26, 2026, 10:40 PM UTC L Barrington Research initiates VMD at Outperform, $14.00 target Barrington Research initiates VMD with an Outperform rating and a $14.00 price target; no catalyst was supplied. EQUITY | Aug 24, 2026, 11:59 AM UTC L Viemed Healthcare Raises FY2026 Sales Guidance from $312.000M-$320.000M to $314.000M-$320.000M vs $317.300M Est Viemed Healthcare (NASDAQ: VMD ) raises FY2026 sales outlook from $312.000 million-$320.000 million to $314.000 million-$320.000 million vs $317.300 million estimate. EARNINGS | Aug 03, 2026, 09:03 PM UTC